Insulet Accelerates the Internationalization of the Omnipod 5 – Growth Rates of 20% Remain Steady!

Insulet (PODD) is regarded as the world's leading provider of tubeless insulin pumps and sees itself as the market leader in automated insulin delivery. Since April 28, Ashley McEvoy has taken over as CEO, bringing extensive experience from her previous leadership role in Johnson & Johnson's medical technology division. She emphasizes: "We are already pioneers in advanced automation." The customer base already exceeds 500,000 active users, with sales in 25 markets. The potential seems far from exhausted with 14 million addressable patients....